K-D MEDICAL, INC.

K-D MEDICAL, INC. specializes in the manufacturing and supply of biological products and laboratory-grade reagents, chemicals, and diagnostic substrates for federal health research and operational needs. The company delivers critical in vitro diagnostic components, culture media, glassware, and lab consumables that support clinical, research, and public health workflows. Their technical expertise lies in GMP-compliant production of non-diagnostic biological substances, precise formulation of laboratory reagents, and end-to-end supply chain management for sensitive biomedical materials. K-D MEDICAL’s differentiation stems from its ability to consistently provide certified, contamination-controlled laboratory essentials that meet stringent federal quality and regulatory standards, ensuring reliability in high-stakes research and diagnostic environments. The contractor maintains a focused relationship with the Department of Health and Human Services, consistently providing essential laboratory supplies and biological manufacturing services to support NIH, CDC, and other HHS-operated research and public health initiatives. Their work directly enables laboratory readiness, infectious disease surveillance, and biomedical experimentation across federal health agencies, establishing a pattern of trusted, recurring procurement for mission-critical consumables. K-D MEDICAL operates primarily within NAICS 325414, which encompasses the manufacturing of biological products excluding diagnostic reagents—such as cell culture media, buffers, enzymes, and chemical precursors used in research and therapeutic development. This positions the company as a niche supplier within the biomedical manufacturing sector, serving the upstream needs of federal laboratories that require validated, non-diagnostic biological materials for experimentation and process development. As a Women-Owned Small Business and Woman-Owned Business certified entity based in Columbia, Maryland, K-D MEDICAL leverages its small business status to serve federal procurement goals while maintaining agile, quality-driven manufacturing processes. The company’s geographic presence in the Mid-Atlantic biotech corridor enhances its ability to respond rapidly to federal agency demands and collaborate with regional research institutions.